Regencell Bioscience Holdings Limited - Ordinary Shares (RGC)

Regencell Bioscience, a Hong Kong-based biotech startup with no reported revenue, has gained more than 59,000% in 2025.

Before the opening bell on Tuesday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.

Regencell Bioscience Holdings (NASDAQ: RGC) shares are soaring Monday after the company's 38-for-one forward stock split officially took effect.

Many retail investors remain wary, with some warning of a looming correction in the absence of formal news or clear catalysts.

Stay up-to-date with the latest market trends one hour before the close of the markets on Thursday. Explore the top gainers and losers during today's session in our detailed report.

Looking for insights into the US markets in the middle of the day on Thursday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.

Top mid-cap stocks gained up to 53.47% in the last week, including QBTS, RGC, AAP, MRUS, OKLO, SBSW, and BGM. Are they in your portfolio?

Curious to know what's happening on the US markets one hour before the close of the markets on Tuesday? Join us as we explore the top gainers and losers in today's session.